Why is Nectar Lifesci. falling/rising?

As of 02-Jul, Nectar Lifescience Ltd's stock price is currently at 22.91, reflecting a slight increase of 0.06, or 0.26%. The stock has been gaining momentum recently, with a 3.34% rise over the last two days, although it has underperformed over the past month with a decline of 8.29%. Despite this recent uptick, the stock's long-term performance remains concerning, as it has generated a return of -26.73% over the past year. The company has shown positive financial results, including a 40% growth in net profit and consistent positive results for the last six quarters. However, the high debt-to-EBITDA ratio of 5.71 times and the fact that 99.6% of promoter shares are pledged raise concerns about its long-term fundamental strength.
In the broader market context, Nectar Lifescience's short-term performance of +2.09% over the past week compares favorably to the Sensex, which has increased by 0.79%. However, the stock's year-to-date performance of -41.26% starkly contrasts with the Sensex's gain of 6.75%, indicating significant underperformance in the longer term. This disparity highlights the challenges the company faces, particularly in servicing its debt and maintaining profitability, which may contribute to investor caution despite recent positive earnings reports.